What is the tissue response expected to be with Neomem® ECM?

Neomem® ECM is an extracellular matrix in sheet form with a combination of strength and tissue regeneration properties with minimal antigens.

Cells grow into Neomem® ECM and it is well integrated within 2 weeks of implantation.  Initially, these cells tend to be inflammatory cells but due to the natural tissue properties, these cells are quickly replaced by fibroblasts that begin laying down new matrix material.  The new matrix gradually replaces the material in the device resulting in a regenerated tissue.